欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/2974/001
药品名称
Brevibloc
活性成分
Esmolol hydrochloride 10.0 MG
剂型
Solution for infusion
上市许可持有人
Baxter A/S Tobaksvejen 23A, 2860 Søborg Denmark
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
PL 00116/0352 - 0026
Germany (DE)
Belgium (BE)
Netherlands (NL)
Ireland (IE)
Spain (ES)
Portugal (PT)
Sweden (SE)
Norway (NO)
Finland (FI)
Cyprus (CY)
Brevibloc 10mg/ml solution for infusion
许可日期
2010/08/25
最近更新日期
2024/10/28
药物ATC编码
C07AB09 esmolol
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
common_pl_2024_09_breviblocinf_2974_var030_c
Date of last change:2024/10/28
Final Labelling
|
common_combined_brevi10inf_ws170_r_seq018_clean
Date of last change:2024/09/06
Final SPC
|
common_spc_brevi10inf_ws170_r_seq018_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase